[A case of gastric carcinoma remarkably responding to etoposide, adriamycin and cisplatin (EAP) therapy].
A 47-year-old male was diagnosed as having gastric cancer with metastases to liver, para-aorta node and Virchow node. He was treated with EAP (Etoposide, Adriamycin, Cisplatin) therapy, as a result of which a partial response was obtained according to the criteria of the Jpn. Soc. Cancer. Ther. The response was disappearance of subjective symptoms and Virchow's metastasis and reduction of chief tumor and liver metastases. However, this therapy was accompanied by severe side effects such as leucopenia and thrombocytopenia, but in this case, these side effects improved within 20 days.
Nakamura
Y
Y
1st Dept. of Surgery, Kinki University School of Medicine, Osaka.
Hamada
H
H
Yoshinobu
H
H
Mori
N
N
Nakajima
I
I
Kurooka
K
K
Tanaka
A
A
Nakamura
T
T
Yasutomi
M
M
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004381:Duodenal Ulcer / Q000601:surgery; D005047:Etoposide / Q000008:administration & dosage; D005743:Gastrectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000209:etiology
D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin